Systemic treatment of hepatocellular carcinoma secondary to non-alcoholic fatty liver disease

Karolina Rzeniewicz, Rohini Sharma · 2024

Read Systemic treatment of hepatocellular carcinoma secondary to non-alcoholic fatty liver disease by Karolina Rzeniewicz, Rohini Sharma (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11514420.txt.

Description

Hepatocellular carcinoma (HCC) is the third leading cause of cancer death globally, with 15% of cases arising on a background of non-alcoholic fatty liver disease (NAFLD). NAFLD is a heterogenous condition ranging from fatty liver to cirrhosis and is itself a growing global problem, with estimated worldwide prevalence of 50% in 2040.

Catalog record

CREATORKarolina Rzeniewicz, Rohini Sharma
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE26 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11514420

Browse the full library · About the Tower of Babel